AzurRx BioPharma Inc
AZRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.43M
Close$
$3.56
3.2% upside
Current Fair Value
3.2% upsideUndervalued by 3.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.43 Million |
|---|---|
| Enterprise Value | $5.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.16 |
| Beta | 1.51 |
| Outstanding Shares | 4,451,298 |
Return
| Return on Equity | -37.00% |
|---|---|
| Return on Assets | -18.21% |
| Return on Invested Capital | -31.12% |
Valuation & Multiples
| P/E Ratio | -1.76 |
|---|---|
| PEG | -1.02 |
| Price to Sales | - |
| Price to Book Ratio | 0.58 |
| Enterprise Value to Revenue | 74.38 |
| Enterprise Value to EBIT | -0.56 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.45 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data